Takeda Pharmaceutical Company Limited Key Management Personnel Compensation Share-based Payment
Takeda Pharmaceutical Company Limited (TAK) reported Key Management Personnel Compensation Share-based Payment of JPY 2.47 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment · last filed 2025-06-25
| Period end | Key Management Personnel Compensation Share-based Payment 12 month |
|---|---|
| 2025-03-31 | 2.47B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 2.75B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 2.40B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 2.55B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 2.48B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 2.14B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 1.30B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 1.18B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 948.00M JPY 20-F · filed 2019-06-27 |